🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 877619106
- Market Cap
- Large Cap
- IPO
- 9/24/2020 · $20.00/share
Business: Taysha Gene Therapies, Inc. is a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations
Company Contact
- CEO
- RA Session II
- CFO
- Kamran Alam
- Headquarters
- 3000 Pegasus Park Drive Ste 1430, Dallas, TX 75247
- Phone
- 214-612-0000
- Investor Relations
- Niren Shah · 214-612-0000 · Nshah@tayshagtx.com